Department of Medicine, Gastrointestinal Division, Liver Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Division of Gastroenterology & Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Liver Transpl. 2024 Sep 1;30(9):918-931. doi: 10.1097/LVT.0000000000000348. Epub 2024 Feb 15.
The financial impact of liver transplantation has been underexplored. We aimed to identify associations between high financial burden (≥10% annual income spent on out-of-pocket medical costs) and work productivity, financial distress (coping behaviors in response to the financial burden), and financial toxicity (health-related quality of life, HRQOL) among adult recipients of liver transplant. Between June 2021 and May 2022, we surveyed 207 adult recipients of liver transplant across 5 US transplant centers. Financial burden and distress were measured by 25 items adapted from national surveys of cancer survivors. Participants also completed the Work Productivity and Activity Impairment and EQ-5D-5L HRQOL questionnaires. In total, 23% of recipients reported high financial burden which was significantly associated with higher daily activity impairment (32.9% vs. 23.3%, p =0.048). In adjusted analyses, the high financial burden was significantly and independently associated with delayed or foregone medical care (adjusted odds ratio, 3.95; 95% CI, 1.85-8.42) and being unable to afford basic necessities (adjusted odds ratio, 5.12; 95% CI: 1.61-16.37). Recipients experiencing high financial burden had significantly lower self-reported HRQOL as measured by the EQ-5D-5L compared to recipients with low financial burden (67.8 vs. 76.1, p =0.008) and an age-matched and sex-matched US general population (67.8 vs. 79.1, p <0.001). In this multicenter cohort study, nearly 1 in 4 adult recipients of liver transplant experienced a high financial burden, which was significantly associated with delayed or foregone medical care and lower self-reported HRQOL. These findings underscore the need to evaluate and address the financial burden in this population before and after transplantation.
肝移植的经济影响尚未得到充分探讨。我们旨在确定高经济负担(用于自付医疗费用的年度收入的 10%以上)与成人肝移植受者的工作生产力、经济困境(应对经济负担的应对行为)和经济毒性(与健康相关的生活质量,HRQOL)之间的关联。在 2021 年 6 月至 2022 年 5 月期间,我们调查了美国 5 个移植中心的 207 名成人肝移植受者。经济负担和困境通过来自全国癌症幸存者调查的 25 项适应项来衡量。参与者还完成了工作生产力和活动障碍以及 EQ-5D-5L HRQOL 问卷。共有 23%的受者报告经济负担高,这与更高的日常活动障碍明显相关(32.9%比 23.3%,p=0.048)。在调整分析中,高经济负担与延迟或放弃医疗保健显著且独立相关(调整后的优势比,3.95;95%置信区间,1.85-8.42),并且无法负担基本必需品(调整后的优势比,5.12;95%置信区间:1.61-16.37)。与经济负担低的受者相比,经历高经济负担的受者自我报告的 HRQOL 明显较低,这是通过 EQ-5D-5L 测量的(67.8 比 76.1,p=0.008),与年龄和性别匹配的美国一般人群相比(67.8 比 79.1,p<0.001)。在这项多中心队列研究中,近四分之一的成人肝移植受者经历了高经济负担,这与延迟或放弃医疗保健和自我报告的 HRQOL 较低显著相关。这些发现强调了在移植前后评估和解决这一人群的经济负担的必要性。